MedTrace Logo

Risk Analysis for Cardiovascular Autonomic Neuropathy

NCT02462616 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2100

Last updated 2017-09-06

No results posted yet for this study

Summary

This is a large-scale, community-based, cross-sectional study to evaluate environmental and genetic risk factors for cardiovascular autonomic neuropathy in general Chinese population.

Conditions

  • Cardiovascular Autonomic Neuropathy

Interventions

OTHER

not intervention

This is a cross-sectional study, no intervention was performed.

Sponsors & Collaborators

  • Huashan Hospital

    collaborator OTHER

  • Shanghai Tongji Hospital, Tongji University School of Medicine

    lead OTHER

Principal Investigators

  • Zihui Tang, M.D and Ph.D · Huashan Hospital

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02462616 on ClinicalTrials.gov